Your browser doesn't support javascript.
loading
Dihydromyricetin improves cardiac insufficiency by inhibiting HMGB1 in diabetic rats / 南方医科大学学报
Article de Zh | WPRIM | ID: wpr-936358
Bibliothèque responsable: WPRO
ABSTRACT
OBJECTIVE@#To investigate the effect of dihydromyricetin (DHM) on cardiac insufficiency in diabetic rats and explore the underlying mechanism.@*METHOD@#Twenty-four male SD rats were randomized equally into normal control group, type 2 diabetes (T2DM) group fed on a high-glucose and high-fat diet for 6 weeks with low-dose streptozotocin (STZ) injection, metformin (MET) group with daily intragastric administration of MET (150 mg/kg) for 8 weeks after T2DM modeling, and dihydromyricetin (DHM) group with daily intragastric administration of DHM (250 mg/kg) for 8 weeks after modeling. The levels of fasting blood glucose, low density lipoprotein (LDL-C), triglyceride (TG), total cholesterol (TC), high density lipoprotein (HDL-C) and glycosylated hemoglobin (HbA1c) of the rats were measured, and plasma levels of insulin and high mobility group protein-1 (HMGB1) were detected with ELISA. The cardiac function of the rats was assessed using color echocardiography, ECG was measured using a biological signal acquisition system, and myocardial pathology was observed with HE staining. The protein expressions of HMGB1, nuclear factor-κB (NF-κB) p65 and phospho-NF-κB p65 (p-NF-κB p65) in the myocardial tissue were detected using Western blotting.@*RESULTS@#Compared with the control group, the rats in T2DM group showed significant anomalies in cardiac function after modeling with significantly increased plasma HMGB1 level and expressions of HMGB1, NF-κB p65 and p-NF-κB p65 proteins in the myocardial tissue (P < 0.05 or 0.01). Treatment with DHM significantly improved the indexes of cardiac function of the diabetic rats (P < 0.05 or 0.01), decreased plasma HMGB1 level and down-regulated the protein expressions of HMGB1 and p-NF-κB p65 in the myocardial tissue (P < 0.05 or 0.01).@*CONCLUSION@#DHM treatment can improve cardiac function in diabetic rats possibly by down-regulation of HMGB1 and phospho-NF-κB p65 expressions in the myocardium.
Sujet(s)
Mots clés
Texte intégral: 1 Indice: WPRIM Sujet Principal: Facteur de transcription NF-kappa B / Rat Sprague-Dawley / Protéine HMGB1 / Flavonols / Diabète expérimental / Diabète de type 2 / Défaillance cardiaque / Metformine Type d'étude: Prognostic_studies Limites du sujet: Animals langue: Zh Texte intégral: Journal of Southern Medical University Année: 2022 Type: Article
Texte intégral: 1 Indice: WPRIM Sujet Principal: Facteur de transcription NF-kappa B / Rat Sprague-Dawley / Protéine HMGB1 / Flavonols / Diabète expérimental / Diabète de type 2 / Défaillance cardiaque / Metformine Type d'étude: Prognostic_studies Limites du sujet: Animals langue: Zh Texte intégral: Journal of Southern Medical University Année: 2022 Type: Article